News Live 2019: Global Immune Checkpoint Inhibitors Market will Rise to High Globally in Next Five Years
Global Immune Checkpoint Inhibitors Market will catch significant CAGR ad the report detailed valued information, major Applications, types and company profiles (Bristol Myer Squibb, AstraZeneca, Merck & Co., Roche / Genentech, Incyte Corporation and more).
DUBLIN, United States – June 20, 2019 /MarketersMedia/ —
Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to suppress the anti-tumor activity of the immune system thereby suppressing the immune response against the cancer cells. The study of these proteins and pathways has led to the development of a number of immune checkpoint inhibitors as therapies against cancer. Initial preclinical studies showed that antibody blockade of the immune checkpoint molecule CTLA-4 resulted in successful anti-tumor immune responses in the murine cancer models. This was then followed by studies targeting the PD-1/PD-L1 pathway. Ipilimumab and Yervoy were the first immune checkpoint inhibitors introduced in the market. With the promising results of Yervoy, several anti-PD-1 and anti-PD-L1 antibodies have been developed. Although there are number of other checkpoints that have been studied, such as LAG-3 and TIM-3, the only approved immune checkpoint inhibitors include CTLA-4, PD-1 and PD-L1.
Download Exclusive Sample PDF Copy of this Report:
https://inforgrowth.com/sample-request/2830374/immune-checkpoint-inhibitors-market
Global Immune Checkpoint Inhibitors Market Research Report 2019 include all basic information related to the global Industry and forecast till 2025. The Immune Checkpoint Inhibitors Market research report serves as a repository of analysis and information for every aspect of the market, including regional markets, technology, types, and applications. The objectives of this study are to define, segment, and project the size of the market based on company, product type, end user and key regions.
Market Segmentation:
This report also studies critical parameters of Point of Immune Checkpoint Inhibitors market like Industry Chain, Raw Materials, Cost, Technology, Consumer Preference, Industry Overall (including but not limited to History, Development & Trend, Market Competition, Trade Overview, Policy, Region, Regional Market, Production Development, Sales, and more
Following Top Companies are mentioned in this Immune Checkpoint Inhibitors Market Report:
Bristol Myer Squibb, AstraZeneca, Merck & Co., Roche / Genentech, Incyte Corporation, NewLink Genetics, ArGEN-X, Seattle Genetics, Pfizer, MacroGenics, Celldex Therapeutics, CureTech, Immutep, Innate Pharma, Sorrento Therapeutics, GlaxoSmithKline, GITR, Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
PD-1/PD-L1, CTLA-4
On the basis of the end users/applications, this Immune Checkpoint Inhibitors Market report focuses on the status and outlook for major applications/end users,
Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Melanoma, Blood Cancer, Other
Get Special Discount Up to 50 at,
https://inforgrowth.com/discount/2830374/immune-checkpoint-inhibitors-market
Research methodology of Immune Checkpoint Inhibitors Market:
Research study on the Immune Checkpoint Inhibitors Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. This report focuses on the global Immune Checkpoint Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Checkpoint Inhibitors development in United States, Europe and China.
Table of Content
1 Study Coverage
1.1 Immune Checkpoint Inhibitors Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Immune Checkpoint Inhibitors Market Size Growth Rate by Type
.
.
.
.
2 Executive Summary
2.1 Global Immune Checkpoint Inhibitors Market Size
2.1.1 Global Immune Checkpoint Inhibitors Revenue 2014-2025
2.1.2 Global Immune Checkpoint Inhibitors Production 2014-2025
2.2 Immune Checkpoint Inhibitors Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape.
.
.
.
.
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
And more…
View Complete Report with Table of Content:
https://inforgrowth.com/report/2830374/immune-checkpoint-inhibitors-market
Contact Info:
Name: Rohan S.
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: 9093292808
Website: https://www.inforgrowth.com/
Source: MarketersMedia
Release ID: 527435
Copyright © 1999-2013 SproutNews.com
